Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 65.98
-2.96 (-4.29%)
At close: Mar 9, 2026
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 91.45M CNY in the quarter ending September 30, 2025, with 32.74% growth. This brings the company's revenue in the last twelve months to 336.73M, up 21.99% year-over-year. In the year 2024, Medprin Regenerative Medical Technologies had annual revenue of 278.44M with 20.61% growth.
Revenue (ttm)
336.73M
Revenue Growth
+21.99%
P/S Ratio
13.07
Revenue / Employee
999.20K
Employees
337
Market Cap
4.40B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hangzhou AGS MedTech | 597.21M |
| Zhejiang Orient Gene Biotech | 958.99M |
| Shanghai Kinetic Medical | 1.02B |
| CareRay Digital Medical Technology | 320.53M |
| Nanjing Medlander Medical Technology | 431.59M |
| Getein Biotech | 1.04B |
| Ningbo David Medical Device | 516.76M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |